Metastasiertes, hormonsensitives Prostatakarzinom: Vorteil durch Enzalutamid hält lange an | Zendy

AI Assistant Blog Pricing

Open Access

Metastasiertes, hormonsensitives Prostatakarzinom: Vorteil durch Enzalutamid hält lange an

Author(s) -

Nicola Siegmund-Schultze

Publication year - 2022

Publication title -

deutsches ärzteblatt

Language(s) - German

Resource type - Journals

eISSN - 0172-2107

pISSN - 0012-1207

DOI - 10.3238/persasco.2022.08.08.10

Subject(s) - gynecology , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.